Back
News

AXA IM makes €500m life sciences leap

AXA Investment Managers has agreed to acquire Kadans Science Partner from funds advised by Oaktree Capital Management.

The fund manager is understood to have bought the Dutch developer for an initial €500m (£439m) investment, according to market sources.

Kadans is a developer, owner and operator of science parks and lab offices in the Netherlands, the UK and Germany. It has 20 assets spanning 1.6m sq ft of operational space and a further seven schemes of 750,000 sq ft to be developed in the next three years.

Start your free trial today

Your trusted daily source of commercial real estate news and analysis. Register now for unlimited digital access throughout April.

Including:

  • Breaking news, interviews and market updates
  • Expert legal commentary, market trends and case law
  • In-depth reports and expert analysis

Up next…